Manzo Pharmaceuticals, Inc.
MNZO
$0.0001
$0.000.00%
OTC PK
09/30/2005 | 06/30/2005 | 03/31/2005 | 12/31/2004 | 09/30/2004 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 6.90K | 147.70K | 1.19M | 9.80K | -- |
Total Receivables | 2.68M | 45.70K | 82.10K | 3.14M | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 498.90K | 1.02M | 1.13M | 138.30K | -- |
Total Current Assets | 3.18M | 1.22M | 2.41M | 3.28M | -- |
|
|||||
Total Current Assets | 3.18M | 1.22M | 2.41M | 3.28M | -- |
Net Property, Plant & Equipment | 804.60K | 809.60K | 1.21M | 1.14M | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 58.80K | -- | -- | -- | -- |
Total Assets | 4.05M | 2.03M | 3.62M | 4.43M | -- |
|
|||||
Total Accounts Payable | 5.60M | 6.65M | 7.18M | 11.86M | -- |
Total Accrued Expenses | 1.29M | 1.05M | 2.77M | 3.52M | -- |
Short-term Debt | 5.12M | 2.86M | 3.08M | 6.52M | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 3.78M | 1.98M | 1.56M | 5.03M | -- |
Total Other Current Liabilities | 3.78M | 1.98M | 1.56M | 5.03M | -- |
Total Current Liabilities | 15.79M | 12.54M | 14.60M | 26.93M | -- |
|
|||||
Total Current Liabilities | 15.79M | 12.54M | 14.60M | 26.93M | -- |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 5.12M | 2.86M | 3.08M | 6.52M | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | 0.00 | -- | -- |
Total Liabilities | 15.79M | 12.54M | 14.60M | 26.93M | -- |
|
|||||
Common Stock & APIC | 10.87M | 10.87M | 9.12M | 8.89M | -- |
Retained Earnings | -22.58M | -21.36M | -20.08M | -31.37M | -- |
Treasury Stock & Other | -28.00K | -25.30K | -24.50K | -24.30K | -- |
Total Common Equity | -11.74M | -10.51M | -10.98M | -22.50M | -- |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -11.74M | -10.51M | -10.98M | -22.50M | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -11.74M | -10.51M | -10.98M | -22.50M | -- |
|